Practice Management News

Amy Comander, MD, DipABLM, was not born a runner.

David J. Benjamin, MD, recently met with a patient who recalled the moment a previous physician had diagnosed him with cancer.

The FDA announced its final decision to rescind approval of melphalan flufenamide, citing safety concerns.

Women in medicine experience significantly higher levels of stress and burnout compared with men in medicine, according to a literature review published in Global Advances in Integrative Medicine and Health.

A miniature, three-dimensional heart model, called the “heart-on-a-chip,” successfully used reprogrammed stem cells to determine cardiotoxicity of cancer drugs on the human heart, according to a study published in Lab on a Chip.

In this episode, host Shikha Jain, MD, speaks with Ashley Sumrall, MD, about advocacy outside of their oncology practices and organizations, what lies ahead for the field of neuro-oncology and more.

The new CMS rule aiming to streamline prior authorization signals a major step forward for primary care, but the process could still use some improvement, according to experts.

Alexandra Miller, MD, PhD, has been named the new chief of the division of neuro-oncology and co-director of the Brain and Spine Tumor Center at NYU Langone Health’s Perlmutter Cancer Center.

Over time, reductions in lung function following exposure to World Trade Center dust heighten the risk for all-cause and cancer-cause mortality, according to results published in Annals of the American Thoracic Society.

Limiting eligibility criteria, recruiting trusted community messengers and reducing financial burdens can help improve diversity of clinical trial enrollees, a panel of professionals said during a Friends of Cancer Research webinar.